Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Illumina Inc (NASDAQ:ILMN)

170.58
Delayed Data
As of Mar 24
 +2.89 / +1.72%
Today’s Change
119.37
Today|||52-Week Range
186.88
+33.22%
Year-to-Date

Today’s Trading

Previous close167.69
Today’s open168.94
Day’s range167.82 - 171.98
Volume874,067
Average volume (3 months)1,208,808
Market cap$25.0B
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)-0.97%
Earnings growth (this year)+9.42%
Earnings growth (next 5 years)+11.00%
Revenue growth (last year)+8.05%
P/E ratio55.6
Price/Sales7.90
Price/Book11.35

Competitors

 Today’s
change
Today’s
% change
BIVVBioverativ Inc-0.17-0.34%
KITEKite Pharma Inc+2.34+3.14%
TECHBio-Techne Corp+0.32+0.31%
NBIXNeurocrine Bioscienc...+0.48+1.16%
Data as of 3:59pm ET, 03/24/2017

Financials

Next reporting dateApril 24, 2017
EPS forecast (this quarter)$0.64
Annual revenue (last year)$2.4B
Annual profit (last year)$454.1M
Net profit margin18.93%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Francis A. deSouza
Chief Financial Officer &
Senior Vice President
Sam A. Samad
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs